Rehmann Capital Advisory Group’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Rehmann Capital Advisory Group’s Portfolio FWP Stock Details FWP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$442	Hold	62	–	–	﹤0.01%	1632
2019 Q2	$407	Buy	62 +27	+77%	+$202	﹤0.01%	1995
2019 Q1	$289	Buy	+35	New	+$294	﹤0.01%	2034

Other funds holding FWP

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

PCG

Private Capital Group West Hartford, Connecticut $133M AUM 11.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rehmann Capital Advisory Group's FWP Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Forward Pharma A/S American Depositary Shares (FWP) position steady in Q3 2019 at 62 shares worth $442. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

Rehmann Capital Advisory Group first reported a position in FWP in Q1 2019 and has held it in 3 quarters since. 10 funds tracked by Wall St. Rank hold FWP as of Q3 2019.

Rehmann Capital Advisory Group held 62 shares of Forward Pharma A/S American Depositary Shares worth $442 as of Q3 2019.
Rehmann Capital Advisory Group left its Forward Pharma A/S American Depositary Shares share count unchanged in Q3 2019.
Forward Pharma A/S American Depositary Shares made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1632 holding.
Rehmann Capital Advisory Group first reported a position in Forward Pharma A/S American Depositary Shares in Q1 2019 and has held it in 3 quarters since.
10 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.